Article Details

Morgan Stanley Sticks to Its Buy Rating for Eli Lilly & Co (LLY) - The Globe and Mail

Retrieved on: 2025-10-04 10:09:41

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley Sticks to Its Buy Rating for Eli Lilly & Co (LLY) - The Globe and Mail. View article details on hiswai:

Excerpt

Flynn covers the Healthcare sector, focusing on stocks such as Gilead Sciences, Bristol-Myers Squibb, and BioNTech SE. In addition to Morgan ...

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo